Ameliorative Role of Mitochondrial Therapy in Cognitive Function of Vascular Dementia Mice
Journal of Alzheimer's Disease · 2024
DOI: 10.3233/jad-230293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, 2024. Verfasst von Deng-Pan Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Pharmacy School, Xuzhou Medical University, Xuzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Dementia, Vascular, Cognitive Dysfunction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Background
Mitochondrial dysfunction plays a vital role in the progression of vascular dementia (VaD). We hypothesized that transfer of exogenous mitochondria might be a beneficial strategy for VaD treatment.
Objective
The study was aimed to investigate the role of mitochondrial therapy in cognitive function of VaD.
Methods
The activity and integrity of isolated mitochondria were detected using MitoTracker and Janus Green B staining assays. After VaD mice were intravenously injected with exogenous mitochondria, Morris water maze and passive avoidance tests were used to detect cognitive function of VaD mice. Haematoxylin and eosin, Nissl, TUNEL, and Golgi staining assays were utilized to measure neuronal and synaptic injury in the hippocampus of VaD mice. Detection kits were performed to detect mitochondrial membrane potential (ΔΨ), SOD activity and the levels of ATP, ROS, and MDA in the brains of VaD mice.
Results
The results showed that isolated mitochondria were intact and active. Mitochondrial therapy could ameliorate cognitive performance of VaD mice. Additionally, mitochondrial administration could attenuate hippocampal neuronal and synaptic injury, improve mitochondrial ΔΨ, ATP level and SOD activity, and reduce ROS and MDA levels in the brains of VaD mice.
Conclusions
The study reports profitable effect of mitochondrial therapy against cognitive impairment of VaD, making mitochondrial treatment become a promising therapeutic strategy for VaD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Pharmacy School, Xuzhou Medical University, Xuzhou, Jiangsu, China.
- Xuzhou Ruihu Health Management Consulting Co., Ltd, Xuzhou, Jiangsu, China.
- School of Basic Medicine, Xuzhou Medical University, Xuzhou, Jiangsu, China.
- Scientific Research Center of Traditional Chinese Medicine, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
Zitieren
APA
Wu, D. P., Wei, Y. S., Du, Y. X., Liu, L. L., Yan, Q. Q., Zhao, Y. D., Yu, C., Liu, J. Y., Zhong, Z. G., & Huang, J. L. (2024). Ameliorative Role of Mitochondrial Therapy in Cognitive Function of Vascular Dementia Mice. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-230293
Vancouver
Wu DP, Wei YS, Du YX, Liu LL, Yan QQ, Zhao YD, et al. Ameliorative Role of Mitochondrial Therapy in Cognitive Function of Vascular Dementia Mice. Journal of Alzheimer's Disease. 2024. doi:10.3233/jad-230293
BibTeX
@article{Wu2024,
author = {Wu, Deng-Pan and Wei, Yan-Su and Du, Yu-Xuan and Liu, Ling-Ling and Yan, Qiu-Qing and Zhao, Yuan-Dan and Yu, Chao and Liu, Jin-Yuan and Zhong, Zhen-Guo and Huang, Jin-Lan},
title = {Ameliorative Role of Mitochondrial Therapy in Cognitive Function of Vascular Dementia Mice},
journal = {Journal of Alzheimer's Disease},
year = {2024},
doi = {10.3233/jad-230293}
}
EUVIMED